News
- Author:
- Christos Evangelou, MSc, PhD
Publish date: May 20, 2024
An ongoing trial is evaluating multiple treatment combinations in patients with locally advanced or metastatic TNBC.
News
- Author:
- Christos Evangelou, MSc, PhD
Publish date: May 17, 2024
Researchers compare maternal and fetal outcomes between those who conceived spontaneously versus those using ART in this high-risk population
News
- Author:
- Christos Evangelou, MSc, PhD
Publish date: April 16, 2024
Researchers evaluate new cfDNA blood-based test’s ability to detect CRC.
News
- Author:
- Christos Evangelou, MSc, PhD
Publish date: April 12, 2024
New study results suggest ctDNA dynamics provide an early window into predicting response to targeted therapies in patients with HER2-altered cance...
News
- Author:
- Christos Evangelou, MSc, PhD
Publish date: April 10, 2024
Eight of 26 patients with cancer signals detected through MCED had cancer.
News
- Author:
- Christos Evangelou, MSc, PhD
Publish date: April 9, 2024
Researchers evaluate the efficacy and safety of first-line cadonilimab plus standard chemotherapy in patients with advanced or metastatic gastric c...
News
- Author:
- Christos Evangelou, MSc, PhD
Publish date: May 8, 2023
Failure to understand the gout disease process and goals of urate-lowering therapy (ULT) is a key barrier to achieving optimal gout therapy.
News
- Author:
- Christos Evangelou, MSc, PhD
Publish date: May 5, 2023
The Mediterranean diet is not only helpful for losing weight but also can reduce the risk of various chronic diseases.
News
- Author:
- Christos Evangelou, MSc, PhD
Publish date: May 4, 2023
Nirmatrelvir-ritonavir has helped keep many patients out of the hospital, says internist.
News
- Author:
- Christos Evangelou, MSc, PhD
Publish date: May 3, 2023
Surgery provides the most weight loss, but has the greatest risk, according to an endocrinology, diabetes, and metabolism professor.
News
- Author:
- Christos Evangelou, MSc, PhD
Publish date: May 1, 2023
“The greatest challenge is cost, as blood-based biomarkers are not currently covered by insurance and still rather costly.”
News
- Author:
- Christos Evangelou, MSc, PhD
Publish date: April 28, 2023
In a major shift in the definition of hypertension, new guidelines reclassified 130/80 mm Hg as high blood pressure.
